stockrowArcutis Biotherapeutics, Inc.
ARQT Healthcare Biotechnology
Arcutis Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 91.3% from fiscal 2024.
- Revenue
- +45.1%
- EPS
- +12.0%
- Free cash flow
- +1,171.9%
- Total debt
- +0.83%
Quarter to September 2026, against a year earlier
Follow ARQT
Alert me
Arcutis Biotherapeutics, Inc. (ARQT) Shares outstanding
Arcutis Biotherapeutics, Inc.'s shares outstanding at the end of fiscal 2025 was $127.2M, up 5.19% from $121.0M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $136.8M. Over the past ten years it has ranged from $695.3K (fiscal 2017) to $127.2M (fiscal 2025) — the current reading is the highest in ten years. Arcutis Biotherapeutics, Inc. ranks 92nd of 600 Biotechnology companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $127.2M | 5.19% |
| FY2024 | $121.0M | 74.53% |
| FY2023 | $69.3M | 25.94% |
| FY2022 | $55.0M | 11.39% |
| FY2021 | $49.4M | 38.51% |
| FY2020 | $35.7M | 1,835.12% |
| FY2019 | $1.8M | 48.68% |
| FY2018 | $1.2M | 78.30% |
| FY2017 | $695.3K | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $136.8M | 0.69% |
| Jun 2026 | $135.9M | 5.05% |
| Mar 2026 | $129.4M | 1.67% |
| Dec 2025 | $127.2M | (4.25%) |
| 27 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| IOVA Iovance Biotherapeutics, Inc. compare | $450.2M |
| ABCL AbCellera Biologics Inc. compare | $305.6M |
| RLAY Relay Therapeutics, Inc. compare | $202.8M |
| LEGN Legend Biotech Corporation Sponsored ADR compare | $193.8M |
| TNGX Tango Therapeutics, Inc. compare | $149.9M |
| ARQT Arcutis Biotherapeutics, Inc. | $135.9M |
| DFTX Definium Therapeutics, Inc. compare | $110.7M |
| EWTX Edgewise Therapeutics, Inc. compare | $107.7M |
| DNTH Dianthus Therapeutics, Inc. compare | $57.3M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on ARQT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Altman Z-score
- Beneish M-score
- The full statement